AI Insight
This study examined how DNA template quality and manufacturing conditions affect the poly(A) tail length of mRNA produced through in vitro transcription. Using direct mass spectrometry analysis, researchers found that mRNA poly(A) tail length and variability are influenced by the DNA template's heterogeneity, design choices, and reaction conditions such as nucleotide concentrations. The study also identified unexpected cytidine additions at the 3'-end of mRNA poly(A) tails, providing mechanistic insights into mRNA synthesis quality control.
Why it matters
As mRNA therapeutics expand beyond vaccines into cancer, metabolic, and autoimmune disease treatments, controlling poly(A) tail length is critical since it affects mRNA stability and translation efficiency. These findings offer manufacturers specific quality control parameters to ensure consistent therapeutic mRNA production.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
mRNA technology has emerged as a powerful new class of medicines. Importantly, this RNA-based approach holds promise for treatments beyond vaccines and infectious diseases, including treatments for cancer, metabolic disorders, cardiovascular conditions and autoimmune diseases. The 3′-polyadenylated (poly(A)) tail of mRNA is required for ribosome initiation, translation, and mRNA stability and is considered a critical quality attribute. In this study, novel direct mass spectrometry approaches were used for the analysis of both the DNA template and corresponding mRNA generated via in vitro transcription. Nucleotide resolution of the poly(A/T) sequence of the DNA template and mRNA poly(A) tail was achieved. The results show that the mRNA poly(A) tail length and heterogeneity is impacted by the heterogeneity of the DNA template, the DNA template design and RNA manufacturing conditions, including relative NTP concentrations. These results provide further important mechanistic insight into the poly(A) tail length and heterogeneity of mRNAs synthesised in vitro, including the identification of 3′-end additions of cytidine to mRNA poly(A) tails. The ability to rapidly assess DNA template quality, combined with monitoring mRNA poly(A) tail length and heterogeneity, is important as part of the characterisation of mRNA precision medicines and ensuring consistent quality of mRNA from manufacturing processes.